Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “antagonist”

678 pharma patents match "antagonist" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 678
Index total 30,257
Page 17 / 29

Quick answer

This filtered view shows 678 pharmaceutical patents matching "antagonist" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

678 results for “antagonist” · 30,257 patents in full index Clear search

  1. US 8487107

    Biphenyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Jul 16, 2013 · Expires Jul 11, 2033

    granted

  2. US 8481563

    8-azabicyclo[3.2.1]octyl-2-hydroxybenzamide compounds as mu opioid receptor antagonists

    Theravance, Inc. · Granted Jul 9, 2013 · Expires Jul 4, 2033

    granted

  3. US 8481738

    Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

    Neurocrine Biosciences, Inc. · Granted Jul 9, 2013 · Expires Jul 4, 2033

    granted

  4. US 8481046

    VEGF antagonist formulations for intravitreal administration

    REGENERON PHARMACEUTICALS, INC. · Granted Jul 9, 2013 · Expires Jul 4, 2033

    granted

  5. US 8455499

    Alkyne antagonists of lysophosphatidic acid receptors

    AMIRA PHARMACEUTICALS, INC. · Granted Jun 4, 2013 · Expires May 30, 2033

    granted

  6. US 8450362

    Amidine-containing compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted May 28, 2013 · Expires May 23, 2033

    granted

  7. US 8440707

    Antagonists of lysophosphatidic acid receptors

    AMIRA PHARMACEUTICALS, INC. · Granted May 14, 2013 · Expires May 9, 2033

    granted

  8. US 8426449

    Aminoalkylphenyl antagonists of prostaglandin D2 receptors

    Panmira Pharmaceuticals, LLC · Granted Apr 23, 2013 · Expires Apr 18, 2033

    granted

  9. US 8414876

    Methods of using IL-1 antagonists to treat autoinflammatory disease

    REGENERON PHARMACEUTICALS, INC. · Granted Apr 9, 2013 · Expires Apr 4, 2033

    granted

  10. US 8404638

    Dimer VEGF antagonist formulations

    REGENERON PHARMACEUTICALS, INC. · Granted Mar 26, 2013 · Expires Mar 21, 2033

    granted

  11. US 8399488

    Biphenyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Mar 19, 2013 · Expires Mar 14, 2033

    granted

  12. US 8383654

    Heterocyclic antagonists of prostaglandin D2 receptors

    Panmira Pharmaceuticals, LLC · Granted Feb 26, 2013 · Expires Feb 21, 2033

    granted

  13. US 8378121

    Quaternary ammonium diphenylmethyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Feb 19, 2013 · Expires Feb 14, 2033

    granted

  14. US 8377966

    Biphenyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Feb 19, 2013 · Expires Feb 14, 2033

    granted

  15. US 8378107

    Heteroaryl antagonists of prostaglandin D2 receptors

    Panmira Pharmaceuticals, LLC · Granted Feb 19, 2013 · Expires Feb 14, 2033

    granted

  16. US 8372848

    Melanin-concentrating hormone receptor antagonists and methods of use

    The Regents of the University of California · Granted Feb 12, 2013 · Expires Feb 7, 2033

    granted

  17. US 8362044

    N,N-disubstituted aminoalkylbiphenyl antagonists of prostaglandin D2 receptors

    Panmira Pharmaceuticals, LLC · Granted Jan 29, 2013 · Expires Jan 24, 2033

    granted

  18. US 8349848

    Pyrrolo[3,2-D]pyrimidines that are selective antagonists of A2B adenosine receptors

    Dogwood Pharmaceuticals, Inc. · Granted Jan 8, 2013 · Expires Jan 3, 2033

    granted

  19. US 8349307

    Polymer conjugates of opioid antagonists

    Nektar Therapeutics · Granted Jan 8, 2013 · Expires Jan 3, 2033

    granted

  20. US 8338424

    Guanidine-containing compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Dec 25, 2012 · Expires Dec 20, 2032

    granted

  21. US 8338484

    N,N-disubstituted aminoalkylbiphenyl antagonists of prostaglandin D2 receptors

    Panmira Pharmaceuticals, LLC · Granted Dec 25, 2012 · Expires Dec 20, 2032

    granted

  22. US 8334282

    Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes

    Jenrin Discovery, LLC · Granted Dec 18, 2012 · Expires Dec 13, 2032

    granted

  23. US 8334239

    High affinity VEGF-receptor antagonists

    The Board of Regents of the University of Texas System · Granted Dec 18, 2012 · Expires Dec 13, 2032

    granted

  24. US 8329911

    Biphenyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Dec 11, 2012 · Expires Dec 6, 2032

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.